WIXOM, MICHIGAN / ACCESS Newswire / May 2, 2025 / Humworld Inc.Humhealth's Advanced Primary Care Management (APCM)Advanced ...

Biomedical Research Leader Aligns with New Federal Public Health Mandate YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / May 2, 2025 / Alpha Genesis, Inc., a national leader in biomedical research and ...

The global Smart Bandages Market is set for strong growth, driven by rapid advancements in healthcare technology and the ...

BELLEVUE, WA / ACCESS Newswire / May 2, 2025 / A new study by Cardia Vision, LLC has revealed that a commonly used heart scan may be missing signs of early heart disease in many patients who appear ...

The developer of sustained acoustic medicine technology and the sam® wearable ultrasound device and number one resource for arthritis information will support the Foundation's efforts to provide ...

The global cannabis use disorder treatment market is poised for strong growth, driven by rising cannabis consumption, the legalisation of cannabis for recreational and medicinal use, and increasing ...

Quarterly / Interim StatementMEDICLIN increases group operating result in the first quarter of 2025 02.05.2025 / 12:58 CET/CESTThe issuer is solely responsible for the content of this ...

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference  Late-breaking oral presentation to highlight further ...

The global prosthetics and orthotics market is poised for substantial growth over the next decade, with projections indicating an increase from USD 7,640 million in 2025 to USD 13,300.5 million by ...

LONDON, GB / ACCESS Newswire / May 2, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that the second patient has been successfully treated as part of the Company's ongoing ...

The global podiatry services market is poised for significant growth, with projections indicating an increase from USD 4,839.6 million in 2024 to USD 6,072.7 million by 2034, reflecting a compound ...

CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing ...